| Full text | |
| Author(s): |
Rozolen, Juliana Moreira
[1]
;
Wichert Teodoro, Tamires Goneli
[2]
;
Sobral, Renata Afonso
[3]
;
Ruiz Sueiro, Felipe Augusto
[4]
;
Laufer-Amorim, Renee
[2]
;
Elias, Fabiana
[5]
;
Fonseca-Alves, Carlos Eduardo
[1, 6]
Total Authors: 7
|
| Affiliation: | [1] Sao Paulo State Univ UNESP, Dept Vet Surg & Anim Reprod, BR-18618681 Botucatu, SP - Brazil
[2] Sao Paulo State Univ UNESP, Dept Vet Clin, BR-18618681 Botucatu, SP - Brazil
[3] ONCO CANE Vet, BR-04084002 Sao Paulo - Brazil
[4] VetPat Vet Lab, BR-13073022 Campinas - Brazil
[5] Fed Univ Fronteira Sul UFFS, Vet Sch, BR-85770000 Realeza - Brazil
[6] Paulista Univ UNIP, Inst Hlth Sci, BR-17048290 Bauru, SP - Brazil
Total Affiliations: 6
|
| Document type: | Journal article |
| Source: | ANIMALS; v. 11, n. 8 AUG 2021. |
| Web of Science Citations: | 0 |
| Abstract | |
Simple Summary Canine splenic hemangiosarcoma (HSA) is an aggressive cancer that originates from endothelial cells. In clinical practice, it is commonly noted among canine patients with ruptured tumors, inducing internal bleeding. Although it is highly important in veterinary medicine, very limited information regarding HSA prognostic markers is available. Thus, this study aimed to evaluate the prognostic value of Claudin-5, prostate-specific membrane antigen (PSMA), and Ki67 in HSA-affected canine patients. We evaluated Claudin-5 and PSMA gene and protein expression, assessed the Ki67 index, and compared these with patients' clinical data. We identified an association between Claudin-5 expression and metastatic status. Patients with higher Claudin-5 expression developed metastasis, and there was an association between PSMA expression and overall survival. Our results suggest that these proteins could be useful prognostic markers for patients with HSA. Splenic hemangiosarcoma (HSA) is a malignant tumor of endothelial cells that affects middle-aged and elderly dogs and is characterized by the formation of new blood vessels, commonly associated with necrotic and hemorrhagic areas. Despite its importance in veterinary medicine, few studies have identified markers with prognostic value for canine HSA. Thus, this study aimed to associate the clinicopathological findings (prostate-specific membrane antigen {[}PSMA], Claudin-5, and Ki67 gene and protein expression) with overall survival in HSA-affected patients. Fifty-three formalin-fixed and paraffin-embedded canine splenic HSA samples, previously diagnosed by histopathological examination, were used in this study. Claudin-5, PSMA, and Ki67 protein expression levels were evaluated by immunohistochemistry, and gene expression was evaluated by quantitative polymerase chain reaction. Claudin-5 protein overexpression was observed in patients with metastasis (p = 0.0078) and with stage III tumors compared to those with stage I and II tumors (p = 0.0451). In patients treated with surgery alone, low PSMA gene and protein expression (p = 0.05 and p = 0.0355, respectively) were associated with longer survival time. Longer survival time was observed in patients with a low Ki67 index (p = 0.0488). Our results indicate that Claudin-5 protein expression is associated with metastatic status, and PSMA gene and protein expression, and Ki67 index are associated with survival time. (AU) | |
| FAPESP's process: | 19/24079-1 - Antitumor effect of Synadenium grantii Hook F. latex on preclinical models of mammary gland tumors |
| Grantee: | Carlos Eduardo Fonseca Alves |
| Support Opportunities: | Regular Research Grants |